1.68
+0.07(+4.35%)
Currency In USD
| Previous Close | 1.61 |
| Open | 1.62 |
| Day High | 1.85 |
| Day Low | 1.62 |
| 52-Week High | 3.25 |
| 52-Week Low | 0.4 |
| Volume | 1.3M |
| Average Volume | 5.17M |
| Market Cap | 34.85M |
| PE | -6.22 |
| EPS | -0.27 |
| Moving Average 50 Days | 1.16 |
| Moving Average 200 Days | 1.11 |
| Change | 0.07 |
If you invested $1000 in Kairos Pharma, Ltd. (KAPA) since IPO date, it would be worth $646.15 as of September 17, 2025 at a share price of $1.68. Whereas If you bought $1000 worth of Kairos Pharma, Ltd. (KAPA) shares 6 months ago, it would be worth $1,768.42 as of September 17, 2025 at a share price of $1.68.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Kapa Gold Announces Accelerated Warrant Exercise
Newsfile
Yesterday at 2:08 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2025) - KAPA GOLD INC. (TSXV: KAPA) ("Kapa" or the "Company") is pleased to announce that further to its news release of August 11, 2025, 3,552,600 warrants (the "Warrants") have been exerc
Kapa Gold Announces Warrant Expiry Date Acceleration
Newsfile
Aug 11, 2025 5:08 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - KAPA GOLD INC. (TSXV: KAPA) ("Kapa" or the "Company") announces that the Company has elected to accelerate the expiry date of certain outstanding common share purchase warrants of the
CEO.CA's Inside the Boardroom: Kairos Pharma CEO on Phase 2 Safety Data, 165% Stock Move & September Efficacy Timeline
Newsfile
Jul 28, 2025 4:28 PM GMT
Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers.Founded in 2012, CEO.CA, a wholly owned s